Literature DB >> 22740886

Transforming growth factor β-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line.

Hui Wang1, Junli Wu, Ye Zhang, Xiaofeng Xue, Dong Tang, Zhongxu Yuan, Minyong Chen, Jishu Wei, Jingjing Zhang, Yi Miao.   

Abstract

The epithelial-mesenchymal transition plays a crucial role in the progression of pancreatic cancer. The aim of this study was to examine the possible association between the epithelial-mesenchymal transition and cancer stem-like cells in pancreatic cancer. We used transforming growth factor β to induce an epithelial-mesenchymal transition. The proportion of pancreatic cancer stem-like cells was measured and sorted by flow cytometry. The expression of markers was measured by quantitative PCR and Western blot analysis. Cell cycle distribution was assessed by flow cytometry. We evaluated the migration and invasion activity by Transwell tests. The proportion of pancreatic cancer stem-like cells was significantly increased following transforming growth factor β treatment. Cells were sorted in culture, the cancer stem-like cells exhibited a higher degree of epithelial-mesenchymal transition and demonstrated upregulation of vimentin, a mesenchymal phenotypic marker, compared to the CD44(-)CD24(-) cells. Pancreatic cancer stem-like cells exhibited greater invasion and migration activity in vitro compared to the CD44(-)CD24(-) cells. These results suggested a direct link between epithelial-mesenchymal transition and cancer stem-like cells in pancreatic cancer.

Entities:  

Year:  2011        PMID: 22740886      PMCID: PMC3362468          DOI: 10.3892/ol.2011.448

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

Review 1.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.

Authors:  R T Costello; F Mallet; B Gaugler; D Sainty; C Arnoulet; J A Gastaut; D Olive
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

Review 6.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

Review 7.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

8.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 9.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  18 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  Discovering the route from inflammation to pancreatic cancer.

Authors:  N Momi; S Kaur; S R Krishn; S K Batra
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

Review 3.  Immune targeting of cancer stem cells in gastrointestinal oncology.

Authors:  Robert J Canter; Steven K Grossenbacher; Erik Ames; William J Murphy
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 4.  TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.

Authors:  Mai Abdel Mouti; Siim Pauklin
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

5.  Understanding the colon cancer stem cells and perspectives on treatment.

Authors:  Elsa N Garza-Treviño; Herminia G Martínez-Rodríguez; Salvador L Said-Fernández
Journal:  Cancer Cell Int       Date:  2015-01-28       Impact factor: 5.722

6.  Caffeic Acid phenethyl ester inhibits epithelial-mesenchymal transition of human pancreatic cancer cells.

Authors:  Ming-Jen Chen; Shou-Chuan Shih; Horng-Yuan Wang; Ching-Chung Lin; Chia-Yuan Liu; Tsang-En Wang; Cheng-Hsin Chu; Yu-Jen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

7.  TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.

Authors:  Nicholas Redshaw; Carme Camps; Vikas Sharma; Mehdi Motallebipour; Marcela Guzman-Ayala; Spyros Oikonomopoulos; Efstathia Thymiakou; Jiannis Ragoussis; Vasso Episkopou
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

8.  Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.

Authors:  G K Chimal-Ramírez; N A Espinoza-Sánchez; E M Fuentes-Pananá
Journal:  J Oncol       Date:  2013-03-14       Impact factor: 4.375

Review 9.  Links between cancer stem cells and epithelial-mesenchymal transition.

Authors:  Sha-Sha Wang; Jian Jiang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Onco Targets Ther       Date:  2015-10-16       Impact factor: 4.147

10.  HDAC3 mediates smoking-induced pancreatic cancer.

Authors:  Mouad Edderkaoui; Shiping Xu; Chintan Chheda; Susan Morvaridi; Robert W Hu; Paul J Grippo; Emman Mascariñas; Daniel R Principe; Beatrice Knudsen; Jing Xue; Aida Habtezion; Dale Uyeminami; Kent E Pinkerton; Stephen J Pandol
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.